Kindbody, a NYC-based fertility and family-building company, raised $62m in Series C funding.
The round was led by Theresa Sexton, Managing Partner of Claritas Health Ventures, who now joins the Board of Directors, with participation from new investors Bramalea Partners, Monashee Investment Management, and Eldridge, and existing investors GV (formerly Google Ventures), Perceptive Advisors, RRE Ventures, and Rock Springs Capital.
The company intends to use the funds to accelerate growth, enhance its proprietary technology, and expand access to its partner, signature, and mobile clinics.
Founded in 2018 by CEO Gina Bartasi, Kindbody leverages proprietary technology to provide fertility, gynecology, and family-building services at over 300 locations around the country including signature and partner clinics. Its suite of offerings covers the full span of fertility services including egg freezing, IVF, IUI, egg and sperm donation, adoption and surrogacy, and maternity care, to ongoing gynecology and holistic wellness, to local and virtual events supporting community education and LGBTQ+ inclusivity. In addition to direct patient care, the company offers a fertility benefit solution to employers. Kindbody’s proprietary portal and electronic medical record platform enables machine-learning to improve patient outcomes by reducing variable decision making amongst providers.
The leadership team is rounded out by President, Annbeth Eschbach; Chief Medical Officer, Dr. Lynn Westphal; Chief Financial Officer, Meredith Whitney; Chief Commercial Officer, Cindy Gentry; Chief Business and Legal Officer; Shilpa Patel; Founding Physician, Dr. Fahimeh Sasan; and Chief Technology Officer, Richard Forsythe.